Scientific Publications

Export 70 results:
C. Coleman N, Prasanna PGS, Bernhard EJ, Buchsbaum JC, Ahmed MM, Capala J, Obcemea C, Deye JA, Pistenmma DA, Vikram B et al..  2018.  Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism . International Journal of Radiation Oncology*Biology*Physics. 101(2):3.
Dosanjh M, Bernier J.  2018.  Advances in Particle Therapy: A Multidisciplinary Approach. Series in Medical Physics and Biomedical Engineering. :282Pages.
Dosanjh M.  2018.  The changing landscape of cancer therapy. 2018
Pistenmaa DA, Dosanjh M, Amaldi U, Jaffray D, Zubizarreta E, Holt K, Lievens Y, Pipman Y, C. Coleman N, Participants forthe Worksh.  2018.  Changing the global radiation therapy paradigm. Radiotherapy and Oncology.
Dosanjh M, Amaldi U, Mayer R, Poetter R, community ENLIGHT.  2018.  ENLIGHT: European network for Light ion hadron therapy. Radiotherapy & Oncology - The Green Journal.
Dosanjh M, Jones B, Pawelke J, Pruschy M, Sørensen BSingers.  2018.  Overview of research and therapy facilities for radiobiological experimental work in particle therapy. Report from the European Particle Therapy Network radiobiology group. Radiotherapy and Oncology. 128(1):14-18.
Pötter R, Balosso J, Baumann M, Berth C, Davies J, Enghardt W, Fossati P, Harris S, Jones B, Krämer M et al..  2018.  Union of light ion therapy centers in Europe (ULICE EC FP7) – Objectives and achievements of joint research activities. Radiotherapy and Oncology. 128(1):83-100.
Cantone MClaire, Ciocca M, Dionisi F, Fossati P, Lorentini S, Krengli M, Molinelli S, Orecchia R, Schwarz M, Veronese I et al..  2013.  Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy.. Radiat Oncol. 8(1):127.
Jereczek-Fossa BA, Bossi-Zanetti I, Mauro R, Beltramo G, Fariselli L, Bianchi LC, Fodor C, Fossati P, Baroni G, Orecchia R.  2013.  CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer : A prospective evaluation of 95 patients/118 lesions.. Strahlenther Onkol. 189(6):448-455.
Robert C, Dedes G, Battistoni G, Böhlen TT, Buvat I, Cerutti F, Chin MPW, Ferrari A, Gueth P, Kurz C et al..  2013.  Distributions of secondary particles in proton and carbon-ion therapy: a comparison between GATE/Geant4 and FLUKA Monte Carlo codes.. Phys Med Biol. 58(9):2879-99.
Molinelli S, Mairani A, Mirandola A, G Freixas V, Tessonnier T, Giordanengo S, Parodi K, Ciocca M, Orecchia R.  2013.  Dosimetric accuracy assessment of a treatment plan verification system for scanned proton beam radiotherapy: one-year experimental results and Monte Carlo analysis of the involved uncertainties.. Phys Med Biol. 58(11):3837-47.
Barazzuol L, Jena R, Burnet NG, Meira LB, Jeynes JCG, Kirkby KJ, Kirkby NF.  2013.  Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma.. Radiat Oncol. 8:65.
Rinaldi I, Brons S, Gordon J, Panse R, Voss B, Jäkel O, Parodi K.  2013.  Experimental characterization of a prototype detector system for carbon ion radiography and tomography.. Phys Med Biol. 58(3):413-27.
Habermehl D, Debus J, Ganten T, Ganten M-K, Bauer J, Brecht IC, Brons S, Haberer T, Haertig M, Jäkel O et al..  2013.  Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.. Radiat Oncol. 8:59.
Bauer J, Unholtz D, Sommerer F, Kurz C, Haberer T, Herfarth K, Welzel T, Combs SE, Debus J, Parodi K.  2013.  Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment.. Radiother Oncol. 107(2):218-26.
Scifoni E, Tinganelli W, Weyrather WK, Durante M, Maier A, Krämer M.  2013.  Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification.. Phys Med Biol. 58(11):3871-95.
Sánchez-Parcerisa D, Gemmel A, Jäkel O, Rietzel E, Parodi K.  2013.  Influence of the delta ray production threshold on water-to-air stopping power ratio calculations for carbon ion beam radiotherapy.. Phys Med Biol. 58(1):145-58.
Mairani A, Böhlen TT, Dokic I, Cabal G, Brons S, Haberer T.  2013.  Modelling of cell killing due to sparsely ionizing radiation in normoxic and hypoxic conditions and an extension to high LET radiation.. Int J Radiat Biol.
Mairani A, Böhlen TT, Schiavi A, Tessonnier T, Molinelli S, Brons S, Battistoni G, Parodi K, Patera V.  2013.  A Monte Carlo-based treatment planning tool for proton therapy.. Phys Med Biol. 58(8):2471-90.
Dosanjh M, Jones B, Myers S.  2013.  A possible biomedical facility at the European Organization for Nuclear Research (CERN).. Br J Radiol. 86(1025):20120660.
Ski ARuci, Bauer J, Campbell P, Brons S, Unholtz D, Habl G, Herfarth K, Debus J, Bert C, Parodi K et al..  2013.  Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT.. Radiat Oncol. 8(1):134.
Orecchia R, Srivastava A, Fiore MRosaria, Vitolo V, Fossati P, Vischioni B, Iannalfi A, Tuan J, Ciocca M, Molinelli S et al..  2013.  Proton beam radiotherapy: report of the first patient treated at the Centro Nazionale di Adroterapia Oncologica (CNAO).. Tumori. 99(2):34e-7e.


You are here